SCHEMBL7740648

SCHEMBL7740648

CS(=O)(=O)CCCNc1ccccc1[N+](=O)[O-]

nearest known ligand 0.64

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KAT2B Q92831 2/20 0.64
MAPT P10636 10/20 0.56
ALDH1A1 P00352 4/20 0.56
HTT P42858 1/20 0.56
LMNA P02545 3/20 0.53
NPC1 O15118 3/20 0.52
RAB9A P51151 3/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
POLB P06746 2/20 0.48
PKM P14618 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.47
MAPK1 P28482 2/20 0.47
KMT2A Q03164 2/20 0.46
GAA P10253 1/20 0.46
MEN1 O00255 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7170020 0.84 KAT2B (0.81) KAT2BMAPTALDH1A1HTTLMNA
SCHEMBL6200169 0.84 KAT2B (0.81) KAT2BMAPTALDH1A1HTTLMNA
SCHEMBL6198359 0.82 KAT2B (0.78) KAT2BMAPTALDH1A1HTTLMNA
SCHEMBL8720672 0.82 KAT2B (0.78) KAT2BMAPTALDH1A1HTTLMNA
SCHEMBL981345 0.81 KAT2B (0.71) KAT2BMAPTALDH1A1HTTLMNA
SCHEMBL9979903 0.81 MAPT (0.54) KAT2BMAPTLMNASMN1; SMN2POLB
SCHEMBL15685232 0.81 MAPT (0.75) KAT2BMAPTALDH1A1HTTLMNA
SCHEMBL7745227 0.81 MAPT (0.69) KAT2BMAPTALDH1A1HTTLMNA
SCHEMBL6198859 0.81 KAT2B (0.80) KAT2BMAPTALDH1A1HTTLMNA
SCHEMBL1170743 0.80 KAT2B (0.69) KAT2BMAPTALDH1A1HTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6774134-B2 FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION BRISTOL-MYERS SQUIBB COMPANY 2004-08-10 US disclosed
US-6774134-B2 FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION BRISTOL-MYERS SQUIBB COMPANY 2004-08-10 US disclosed